CAN Belhaven BioPharma Series A a Series of CGF2021 LLC — Form D
CAN Belhaven BioPharma Series A a Series of CGF2021 LLC of CLAYMONT, DE, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-08-07. The offering totals $226K, of which $226K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-08-07
- Form: D
- Accession: 0002080346-25-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $226K
- Amount sold: $226K
- Investors: 20
- Date of first sale: 2025-07-22
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-554017
Issuer
- Name: CAN Belhaven BioPharma Series A a Series of CGF2021 LLC
- CIK: 0002080346
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 2093 PHILADELPHIA PIKE, CLAYMONT, DE, 19703
- Phone: (360) 946-0604
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| LLC Sydecar | Director | Claymont, DE |
| Brett Sagan | Executive Officer | Claymont, DE |
More